Drug Pipeline News

Latest News

Contemporary Pediatrics week in review: CDC recommendation for RSV, FDA approved eye drops, and more | Image Credit: © Artur - © Artur - stock.adobe.com.
Contemporary Pediatrics week in review: CDC recommendation for RSV, FDA approved eye drops, and more

September 29th 2023

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Rupa Wong, MD | Image Credit: Rupa Wong, MD
Will FDA approved phentolamine ophthalmic solution 0.75% eye drops impact pediatric care?

September 28th 2023

FDA approves phentolamine ophthalmic solution eye drops for pharmacologically-induced mydriasis | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves phentolamine ophthalmic solution 0.75% eye drops for pharmacologically-induced mydriasis

September 27th 2023

Arcutissubmits roflumilast 0.15% sNDAfor AD in children 6 years and up | Image Credit: © lial88 - © lial88 - stock.adobe.com.
Arcutis submits roflumilast 0.15% sNDA for AD in children 6 years and up

September 21st 2023

Roflumilast cream 0.05% safe, effective for children aged 2 to 5 years with atopic dermatitis | Image Credit: © Марина Терехова - © Марина Терехова - stock.adobe.com.
Roflumilast cream 0.05% safe, effective for children aged 2 to 5 years with atopic dermatitis

September 20th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.